Organ Preservation Market is anticipated to reach a market value of USD 377.97 million by 2030, with a CAGR of 6.93%

The value of the organ preservation market in 2020 was worth USD 193.49 million and is expected to grow at a CAGR of 6.93%, and it is expected to reach a market value of USD 377.97 million by 2030.

Sambalpur, INDIA

New York, United States, June 24, 2022 (GLOBE NEWSWIRE) -- The factors driving the organ preservation market are a rising geriatric population, a rise in traumatic accidents and increasing cases of organ failure.

Pivotal insights of the Organ Preservation Market:

  • North America has the highest market share, which stood at 42.61% of the total market revenue.
  • By Solution, University of Wisconsin solution led the market with a share of 48.08%.
  • By technique, static cold storage held the largest market share of 44.44%.
  • By organ to be preserved, the kidney held the largest market share at 40.28%
  • By end-user, organ transplant centers held the largest market share. 

To get a first-hand overview of the report, Request a Sample at

Pertinent Market Driving Factors:

  • With a rapidly ageing population globally, we would see an increase in the number of organ transplantations to ensure a longer lifespan for the people. According to the UN, the population of people over 60 will outnumber those who are below the age of 5 and below.
  • There are several car accidents where the victims can donate their organs to other patients who require them. According to WHO, more than 1.3 million die of road accidents.
  • There are several singular and multi-organ failure diseases, such as sepsis, cirrhosis, and cardiomyopathy. With the rising number of such diseases, there will be an increased requirement for organ preservatives.

Detailed Segmentation Analysis of Global Organ Preservation Market by Strategic Market Research:

By Organ Type

  • Kidneys
  • Lung
  • Heart
  • Liver
  • Others

By Preservation Technique

  • Hypothermic Machine perfusion
  • Normothermic Machine perfusion
  • Static Cold Storage
  • Others

By Solution

  • Perfadex
  • University of Wisconsin (UW)
  • Custodial HTK
  • Others

By End-User

  • Hospitals
  • Speciality Clinics
  • Organ Transplant Centres
  • Others

By Region

North America

  • Canada
  • USA


  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Rest of Europe

 Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Middle East and Africa

  • South Africa
  • Nigeria
  • UAE
  • Saudi Arabia
  • Turkey
  • Rest of Middle East and Africa

Make a Direct Purchase of the latest Organ Preservation Market Report published in the month of June 2022. Click the below link to initiate the purchase:

Report CoverageDetails
Forecast Period2020-2030
Forecast Period 2021 to 2028 CAGR6.93% 
2030 Value ProjectionUSD 377.97 million
Base Year2020 
Market Size in 2020USD 193.49 million
Historical Data for2015-2019
No. of Pages140 
CompaniesParagonix Technologies, TransMedics, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals, LLC, XVIVO Perfusion AB, Bridge To Life Limited, 21st Century Medicine, Shanghai Genext Medical Technology, OrganOx Limited, Carnamedica, Preservation Solutions, Waters Medical Systems, Transplant Biomedicals, Avionord, Biochefa, Institut Georges Lopez, Organ Preservation Solutions, TX Innovations, SALF., Global Transplant Solutions, Vascular Perfusion Solutions,EBERS
Leading SegmentStatic cold storage segment
Leading RegionNorth America
Segments coveredBy Solution, By Organ Type, By Preservation Technique, By End-User, and Regions
Growth Drivers

Increasing number of road accidents
Rising number of organ failures, Increasing geriatric population

Based on the Organ Type, ‘Kidney’ led the market.

The kidney component of the organ segment dominated the market share at 40.28%. According to the National Kidney Foundation in the US, there are over 90,000 patients awaiting kidney transplants. Further, in 2021, over 24,000 kidney transplants were carried out in the US. According to the Health Resources and Services Administration, over 84% of patients in the US transplant list are for kidneys. Thus, with a rise in the number of required kidney transplants, there will be an increased demand for organ preservation.

Based on preservation technique, ‘static cold storage’ dominated the market.

The reason for the high market share of this technique is due to the low cost and simplicity associated with preserving organs. Thus, it held the largest share of the segment at 44.44%. 

Based on Solutions, the ‘University of Wisconsin solution’ led the market share.

The UW solution is the first organ preservation solution developed at the University of Wisconsin in the 1980s and was approved for use in 1987. According to an EU study, over 34,000 transplants took place in the region. Further, the report states that there was an increase in the number of voluntary organ donations after the European Union’s parliamentary plan to devise methods to meet the rising demand for organ donations. According to the HRSA, there are over 100,000 patients on the transplant list in the US. Thus, with an increasing need for organ transplantations, there would be a sharp surge in the demand for organ preservatives.

By end-user, ‘organ transplantation centers’ dominated the market share.

Organ transplantation centers are medical facilities that specialize in the process of transplanting organs, having specialized units and doctors that perform the procedures.  As per Donor Alliance, which is an organization that aids in organ transplants, there are over 250 organ transplantation centers in the US, of which 4 are in the service area of Donor Alliance. Thus, with a rising number of such centers, there will be a rise in the requirement for organ preservatives. 

By region, ‘North America’ dominated the market.

US and Canada are countries with advanced healthcare infrastructure and regularly perform organ transplants in the region. According to the Canadian Institute of Health Information (CIHI), 2,782 transplant procedures were carried out in 2021. Further, as of 31st December 2021, there were 4,043 patients on the waiting list. According to the HRSA, over 40,000 transplants were carried out in the US in 2021, with a further 106,098 patients on the transplant waiting list. Thus, with high transplant numbers, we would see the requirement for organ preservatives further increase.

Before initiating a purchase, make a Pre-order enquiry and get a detailed overview of the content of the report.

Key Players in the Organ Preservatives Market:

The major companies involved in the market are as follows:

  • XVIVO Perfusion AB
  • Bridge To Life Limited
  • TransMedics
  • 21st Century Medicine
  • Dr. Franz Köhler Chemie GmbH
  • Paragonix Technologies
  • OrganOx Limited
  • Carnamedica
  • Avionord
  • Biochefa
  • Essential Pharmaceuticals, LLC
  • Shanghai Genext Medical Technology
  • Preservation Solutions
  • Waters Medical Systems
  • Transplant Biomedicals
  • Global Transplant Solutions
  • Vascular Perfusion Solutions
  • Institut Georges Lopez
  • Organ Preservation Solutions
  • TX Innovations
  • SALF.

Kindly go through and get access to our comprehensive coverage of myriad number of Healthcare reports published in the last three months:

Recent Developments in the Market

  • In June 2022, a team of researchers developed a new cryoprotectant that does not damage the cells. Traditional cryopreservation techniques tend to damage cells in the process of storage. However, the team at RMIT University, Melbourne, found that the new chemical showed less toxicity and was able to preserve the cells better.

  • In June 2022, Paragonix Technologies, Inc. announced that it is receiving wider adoption of its new LIVERguard ™ System across medical facilities in the US. The System is an advanced technique to preserve donor liver through cryopreservation and providing real-time data of the same.

  • In June 2022, a study found that a patient had normal liver functions after being transplanted a liver that was on a warm machine perfusion for three days. The study had extensive parameters, including periodic checks of the patient and a one-year post-op complete LFT and psychological evaluation. The results were found to be at levels of patients who had liver transplants with the international guideline of a 12-hour window of preservation of livers. 

  • In May 2022, OrganX, a startup, received funding to further develop their technology that would improve organ preservation. Their technology would try and implement active perfusion, which would enable the organ to be in similar conditions when it is successfully transplanted into the recipient.

  • In May 2022, X-Therma, Inc. announced that they received ‘breakthrough device’ status from the FDA for their new products - XT-Vivo® solution and TimeSeal® Organ Transport Device. This is significant in the preservation market, as it brings better technology available to consumers. 

Related Reports

Global Atherectomy Devices Market Report

The Atherectomy Devices Market report, as formulated by SMR, is a comprehensive report that includes the market drivers, the opportunities available in the market, and its restraints. In 2020, the market was worth USD 990 million and, with a CAGR of 7.34%, is expected to attain a value of USD 2.02 billion by 2030. The factors driving the market are the rising number of geriatric patients, increasing preference for minimally invasive surgeries and overall advancement of technology in the field. The main companies involved in the sector are Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Medtronic, Becton, Rex Medical, AngioDynamics, Dickinson and Company (BD Interventional), and Avinger, Inc.

Global C-Arms Market Report

The C-Arms market report as developed by SMR is an all-inclusive report that mentions the market drivers, the future scope of the market and the limiting factors of the market. In 2020, the C- Arms market was worth USD 1.6 billion and is expected to grow at a CAGR of 4.96% and take the market value up to 2.6 billion by 2030. The factors propelling the growth are the increasing number of chronic diseases and the rising number of microsurgical procedures. The main companies involved in the market are GE Healthcare, DMS Imaging, Siemens Healthineers AG, Hologic, Inc., Koninklijke Philips NV, Canon Medical Systems Corporation, and ATON GmbH (Ziehm Imaging, Inc. and OrthoScan, Inc.), Shimadzu Corporation, C-Arms International, Eurocolombuss.r.l

Global Laparoscopy Devices Market Report

The ‘Laparoscopy Devices Market’ report is an encompassing report by SMR which includes the market drivers, the opportunities in the market and the restraints. In 2020, the market was USD 10.3 billion and, with a CAGR of 7.8%, is expected to reach a value of USD 21.83 billion by 2030. The market drivers are the increasing number of patients with chronic illnesses and the preference for minimally invasive surgeries. The key players in the worldwide market are Johnson & Johnson, Olympus Corporation, Smith & Nephew Plc, Karl Storz SE & CO. KG, Intuitive Surgical, Medtronic Plc. (Covidien), Richard Wolf GmbH, and Stryker Corporation.

Global Ventricular Assist Devices Market Report

The ‘Ventricular Assist Devices Market report is a comprehensive report formulated by SMR that detail the market drivers, the opportunities and the restraints of the market. In 2020, the Ventricular Assist Devices market was worth USD 1.3 billion and is expected to grow at a CAGR of 7.3% and attain a value of USD 2.59 billion by 2030. The factors driving the market are the rising number of patients with cardiovascular disease, an ascending number of geriatric patients, and rapid technological advancements. The pivotal key players operating in the market are Abbott Laboratories, CardioDyme, World Heart Corporation, Medtronic, Teleflex Incorporated, SynCardia Systems, Abiomed, Fresenius Medical Care AG & Co., Getinge, CardiacAssist Inc., Berlin Heart, Jarvik Heart Inc., and SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.

Global Intravascular Temperature Management Market Report

The ‘Intravascular Temperature Management Market’ report, as defined by SMR, is an all-inclusive report that includes market drivers, future scope for companies trying to enter the market and the restraints of the market. In 2020, the market value was USD 268.13 billion, and at a CAGR of 4.14% is expected to grow to a value of USD 405.18 billion by 2030. The factors driving the market are the increasing number of surgical procedures, increasing number of patients with cardiovascular disease and rising awareness to use the devices. The pertinent players operating in the market are 3M, Belmont Instruments, Zoll Medical, Smiths Group PLC., The Surgical Company, BV., Biegler, Stihler Electronic GmbH, BD company, Geratherm Medical AG, and Stryker Corporation. 

About Us:
Strategic Market Research facilitates the organizations globally in taking pivotal business decisions by furnishing the Syndicated and Customized Research Reports, which are highly precise in terms of market numbers. We believe that every firm, whether it is a startup which is in the Introduction stage of the Product Life cycle or an established one which is at the growth stage, requires market research services in order to streamline its key business blueprint. It may be related to Product Launch, Go to Market strategies, Competitive Analysis or new geographical penetration and expansion.

Contact Us:
Strategic Market Research LLP.
Sunil Kumar 
US: +1-8317045538
UK: +441256636046
India: +91-8260836500
Press Release:

Connect Us: